Retatrutide Benefits: What Phase 2 and Phase 3 Evidence Actually Shows
Review retatrutide research on weight, glucose, liver fat and obesity complications—and see which findings are published or still topline.
BPC-157 + TB-500 Blend Labels: Does “10 mg” Mean Total or Per Component?
A BPC-157 + TB-500 blend marked 10 mg may be unclear. Learn how to confirm each component, total content, identity testing and wholesale kit terms.
CJC-1295 With DAC vs Without DAC: What a Wholesale Buyer Must Specify
Buying CJC-1295 wholesale? Learn why “with DAC,” “without DAC” and “CJC-1295” alone can describe different materials—and what to put in an RFQ.
Glutathione Turned Yellow or Smells Different? What a Buyer Can Actually Verify
Glutathione changed from clear to yellow or smells different? Learn what sensory changes cannot prove and which lot records and tests a B2B case needs.
Peptide Purity vs Content: Why “99%” Does Not Answer “How Many Milligrams?”
A clear guide for B2B buyers to HPLC purity, net peptide content and mg per vial: what each number measures, and what to ask before comparing suppliers.
Tesamorelin Benefits: Visceral Fat Evidence, Weight-Neutral Results and Important Limits
Review tesamorelin benefits in human trials, its FDA-approved HIV-lipodystrophy use, visceral-fat results, weight-neutral effect and safety limits.
AOD-9604 Benefits: Why the Largest Weight-Loss Trial Matters Most
Review AOD-9604 benefits, early human signals, the largest 24-week obesity trial, safety limits and what research buyers should verify.
Selank Benefits: What Small Human Studies Show—and What They Cannot Prove
Review Selank benefits, small anxiety-disorder studies, proposed GABA and enkephalin mechanisms, FDA concerns and the evidence still missing.
TB-500 Benefits: Why Thymosin Beta-4 Research Is Not the Same Evidence
Review TB-500 benefits, the seven-amino-acid fragment, thymosin beta-4 studies, FDA findings and the evidence human research has not established.
